Silver Book Fact

AFib, an economic burden

Fact image

AFib is a major economic burden for the U.S. with at least $6.65 billion in healthcare costs attributable to the disease each year. This estimate may be low. One study estimates that Medicare alone pays $15.7 billion per year to treat newly diagnosed AFib patients.

Lee W, Lamas G, Balu S, Spalding J, et al. Direct Treatment Cost of Atrial Fibrillation in the Elderly American Population: A Medicare perspective. J Med Econ. 2008; 11(2). http://www.ncbi.nlm.nih.gov/pubmed/19450086

Coyne KS, Paramore C, Grandy S, Mercader M, et al. Assessing the Direct Costs of Treating Nonvalvular Atrial Fibrillation in the United States. Value in Health. 2006; 9(5). http://www.ncbi.nlm.nih.gov/pubmed/16961553

Reference

Title
Direct Treatment Cost of Atrial Fibrillation in the Elderly American Population: A Medicare perspective
Publication
J Med Econ
Publication Date
2008
Authors
Lee W, Lamas G, Balu S, Spalding J, et al.
Volume & Issue
Volume 11, Issue 2
Pages
281-98
URL
Read Full Resource
Title
Assessing the Direct Costs of Treating Nonvalvular Atrial Fibrillation in the United States
Publication
Value in Health
Publication Date
2006
Authors
Coyne KS, Paramore C, Grandy S, Mercader M, et al.
Volume & Issue
Volume 9, Issue 5
Pages
348-56
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • The heart can beat upwards of 175 times or more per minute during an AFib episode.  
  • Total medical costs for Afib patients over 15-month period
    A study of Medicare beneficiaries with atrial fibrillation found that total medical costs for treating these patients during a 15-month follow-up period were an average of $24,000 per patient—63% of…  
  • Lifetime risk of atrial fibrillation
    At age 80, the remaining lifetime risk of atrial fibrillation is around 22%.  
  • AFib strokes occurring in patients 75+
    Close to half of all atrial fibrillation associated strokes occur in patients age 75 and older.  
  • Atrial fibrillation costs
    Around 73% of total U.S. atrial fibrillation costs are for inpatient expenses.